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Abstract
As South and Central American countries prepare for increased birth defects from
Zika virus outbreaks and plan for mitigation strategies to minimize ongoing and future
outbreaks, understanding important characteristics of Zika outbreaks and how they
vary across regions is a challenging and important problem. We developed a mathe-
matical model for the 2015 Zika virus outbreak dynamics in Colombia, El Salvador, and
Suriname. We fit the model to publicly available data provided by the Pan American
Health Organization, using Approximate Bayesian Computation to estimate parame-
ter distributions and provide uncertainty quantification. An important model input is
the at-risk susceptible population, which can vary with a number of factors including
climate, elevation, population density, and socio-economic status. We informed this
initial condition using the highest historically reported dengue incidence modified by
the probable dengue reporting rates in the chosen countries. The model indicated that
a country-level analysis was not appropriate for Colombia. We then estimated the basic
reproduction number, or the expected number of new human infections arising from a
single infected human, to range between 4 and 6 for El Salvador and Suriname with a
median of 4.3 and 5.3, respectively. We estimated the reporting rate to be around 16%
in El Salvador and 18% in Suriname with estimated total outbreak sizes of 73,395 and
21,647 people, respectively. The uncertainty in parameter estimates highlights a need
for research and data collection that will better constrain parameter ranges.
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1 INTRODUCTION
Mosquito-borne diseases contribute significantly to the overall morbidity and mortality
caused by infectious diseases in Central and South America. Newly emergent pathogens,
such as Zika virus in 2015, highlight the need for data and models to understand the
public health impact of associated diseases and develop mitigation strategies to combat
their spread. In particular, since Zika virus is a newly emergent pathogen in the Americas,
its impact on the na¨ıve population is relatively unknown.
The disease was first discovered in isolation from a rhesus macaque in the Zika forest of
Uganda in 1974 [42]. While infrequent human cases were confirmed in later years in both
Africa and Southeast Asia, it was not until April 2007 that an outbreak outside of these
traditional areas occurred on Yap Island in the North Pacific [12], and this was followed by
another outbreak occurring in French Polynesia beginning October of 2013 [20]. However,
the most significant Zika outbreak began within Central and South America in 2015 [44]
and is currently ongoing. Thus far it has resulted in an estimated 714,636 infections,
which includes both suspected and confirmed cases within Latin American and Non-Latin
Caribbean countries (accessed Jan 10, 2017) [32]. This study focuses on the behavior of
the current burgeoning epidemic in Colombia, El Salvador, and Suriname.
Zika is transmitted to humans primarily through bites from infected Aedes aegypti
and Aedes albopictus mosquitoes. The transmission is in both directions, that is, infected
mosquitoes infect humans and infected humans infect mosquitoes. Upon transmission of
the virus from mosquito to human, an individual will become infectious within 3 to 12
days. Symptoms of infection include fever, rash, joint pain, conjunctivitis, muscle pain
and headache. Recovery from Zika virus disease may require anywhere from 3 to 14 days
after becoming infectious, but once contracted humans are immune from the virus for life.
Many people infected with Zika may be asymptomatic or will only display mild symptoms
that do not require medical attention. An estimated 80% of persons infected with Zika
virus are asymptomatic [33, 12, 6]. Thus, there is a high occurrence of under-reporting for
confirmed or suspected Zika cases. In fact, the number of infected individuals who report
their symptoms is estimated to be between 7% and 17% [20] of the total number infected
by the virus.
Zika can also be transmitted vertically, as a mother can pass the virus to her child
during pregnancy, and this can lead to a variety of developmental issues. Most notably,
Zika is a cause of microcephaly and other severe fetal brain defects [7]. Recent evidence
further suggests an association between the virus and a higher incidence of Guillain-Barre´
syndrome, a disease in which the immune system damages nerve cells causing muscle
weakness and sometimes paralysis [4]. The potential for sexual transmission of Zika virus
has also been confirmed [9]. For instance, the Center for Disease Control (CDC) has
determined that Zika can remain in semen longer than in other body fluids, including
vaginal fluids, urine, and blood. It should be noted, however, that while these latter
means of transmission exist, the number of new human infections produced in this way is
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relatively low compared to mosquito-borne infections [5, 38], and therefore, in the interest of
simplicity and reducing the number of parameters to fit, we will neglect them in formulating
a model.
In general, mathematical modeling has been extensively used to understand disease
dynamics and the impact of mitigation strategies [18]. A few recent papers have developed
models that focus on the behavior of the Zika epidemic. For example, Gao et al. [17],
proposed an SEIR/SEI model to understand the effects of sexually transmitted Zika in
Brazil, Colombia, and El Salvador. The authors did not, however, distinguish between
countries as they assume that the three nations of interest share common parameter values.
Additionally, Towers et al. [38] presented a model that incorporates spatial heterogeneity
in populations at a granular level. Their model focused specifically on the spread of Zika
within Barranquilla, Colombia and included a sexual transmission term, but concluded that
the effects are not significant enough to sustain the disease in the absence of mosquitoes. An
approximation of the basic reproductive number was obtained using maximum likelihood
methods. Finally, a study of the impact of short term dispersal on the dynamics of Zika
virus is analyzed in [27]. The model formulated within [27] does distinguish between
asymptomatic and symptomatic infected populations, and focuses on the estimation of the
reproductive number between two close communities.
In contrast to previous studies, we adopt a more global approach to understanding the
dynamics of the current Zika epidemic and present a model that can be used to study disease
transmission at the country level. We identify differences between countries in regards to
parameter values and reproductive numbers. We discuss the appropriateness of country
level analysis for Colombia, El Salvador, and Suriname and quantify the uncertainty within
the resulting biological parameter values.
In the following section, we develop a Susceptible-Exposed-Infectious-Recovered (SEIR)
/SEI type model which distinguishes between the reported infected population, who are
considered symptomatic, and the unreported infected population, who may be asymp-
tomatic or experience symptoms that are not severe enough to seek medical attention.
The data available from the Pan American Health Organization (PAHO) serves to moti-
vate the use of a split infectious population. The number of reported cases of Zika, both
suspected and confirmed, is reported from PAHO by country. Hence, we develop a model
for three countries of interest assuming that the dynamics of the disease within each may
be associated with different parameter values. In Section 3, we address the additional
complication that the total population of a country cannot be used as the initial suscepti-
ble population due to the biology and bionomics of the Aedes species and human contact
with them, varying in regards to temperature, humidity [14], sanitation, demographics and
elevation [23]. Not everyone within a country is equally susceptible to the Zika infection
due to geographic diversity; hence, we calculate the unique at-risk population within each
country to use as the initial susceptible population. Using the deterministic model at base-
line parameter values, the at-risk population we compute yields realistic initial conditions
that compare well with PAHO data. With the initial population sizes for the epidemic
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in each country known and fixed, we embed the deterministic system into a stochastic
process to quantify the uncertainty of the parameter values. This method allows us to
use biologically valid parameter ranges and Approximate Bayesian Computation (ABC)
methods to obtain parameter distributions that are distinct to each country. Section 4
provides a detailed explanation of our implementation of the ABC method along with the
strengths and weaknesses discovered in applying this method to our particular model. We
summarize the results of the obtained posterior distributions in Section 5. The last section
is dedicated to discussion and conclusions.
2 A Deterministic Zika Model
2.1 Vector-borne SEIR Model with Case Reporting
Sh Eh
Irh
Ih
Rh
Sv Ev Iv
λh
ψνh
(1− ψ)νh
γh
γh
λv νv
Figure 1: A schematic representation of (1), modeling the progression of Zika in human populations,
denoted by green circles, and mosquito populations, represented with red circles. Susceptible humans start
in Sh, and move to Eh, the exposed population, once infected by a mosquito carrying the virus. After
an intrinsic incubation period, exposed individuals become infectious and transition to either the reported
infectious population, Irh , or the unreported infectious population, Ir. Infectious humans will then move
to and remain in Rh after recovering from the infection. The susceptible mosquito population is denoted
Sv. After transmission occurs from bitting an infectious human, susceptible mosquitoes transition to the
exposed population, Ev. The end of the extrinsic incubation period marks the exposed mosquitoes shift to
the infectious class Iv, where they remain infectious until death.
The spread of Zika relies primarily on interactions between humans and mosquitoes. In Fig-
ure 1, members of the at-risk human population, Sh, are bitten by an infectious mosquito
and become exposed, or infected without yet being infectious, at a rate λh. Humans within
the exposed population, Eh, progress from this state to the infectious compartment at a
per capita rate, νh. Note that there is a portion of infectious humans who are either asymp-
tomatic or experience less severe symptoms, and therefore go unreported. The parameter
ψ denotes the proportion of humans who seek medical assistance and are reported as either
4
Sh Number of susceptible humans
Eh Number of infected humans who are not yet infectious
Irh Number of reported infectious humans
Ih Number of unreported infectious humans
Rh Number of recovered humans
Sv Number of susceptible mosquitos
Ev Number of infected mosquitos who are not yet infectious
Iv Number of infectious mosquitos
Table 1: Description of human and mosquito populations state variables
suspected or confirmed Zika patients. Thus, there are two categories for infectious humans:
Irh , the reported infectious population, and Ih, the unreported infectious population. Both
infectious populations then recover at the same per capita rate of γh, where
1
γh
is the aver-
age time spent as infectious. Upon recovery, humans acquire lifetime immunity. Similarly,
a member of the susceptible mosquito population, Sv, becomes exposed at a rate λv when
susceptible mosquitoes bite an infectious human, resulting in transmission. The exposed
mosquitoes, Ev, transition to the infectious compartment at a per capita rate νv, where
1
νv
is the average extrinsic incubation period. Once a mosquito is infectious it will remain so
for the duration of its lifespan which can range between 8−35 days [1, 29, 14]. Finally, be-
cause of the long duration of infection for mosquitoes relative to their lifespan, demography
(i.e., births and deaths) is included within their population dynamics. In total, the system
is described by the following eight coupled, nonlinear ordinary differential equations:
dSh
dt
= −λh(t)Sh
dEh
dt
= λh(t)Sh − νhEh
dIrh
dt
= ψνhEh − γhIrh
dIh
dt
= (1− ψ)νhEh − γhIh
dRh
dt
= γhIrh + γhIh
dSv
dt
= µvNv − λv(t)Sv − µvSv
dEv
dt
= λv(t)Sv − νvEv − µvEv
dIv
dt
= νvEv − µvIv.


(1)
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The population state variables are described within Table 1 and parameters are pre-
sented in Table 2. The quantities Nh and Nv represent the total populations of humans
and mosquitoes within the model, and remain constant. We note that the equation for the
evolution of Rh(t) decouples from the system, as it is determined merely by computing the
remaining population values.
σv Number of times a single mosquito bites a human per unit time.
The average number of days between bites is 1/σv . (Time−1)
βhv Probability of pathogen transmission from an infectious mosquito to a
susceptible human given that a contact between the two occurs. (Dimensionless)
βvh Probability of pathogen transmission from an infectious human to a
susceptible mosquito given that a contact between the two occurs. (Dimensionless)
νh Per capita rate of progression of humans from the exposed state to
the infectious state. The average duration of the latent period is 1/νh. (Time
−1)
γh Per capita recovery rate for humans from the exposed state to the
infectious state. The average duration of the infectious period is 1/γh . (Time
−1)
ψ Proportion of the infected human population that is reported. (Dimensionless)
νv Per capita rate of progression of mosquitoes from the exposed state to the infectious state.
The average duration of the extrinsic incubation period is 1/νv. (Time−1)
µv Density-independent death rate for mosquitoes.
The average lifespan of a mosquito is 1/µv . (Time−1)
λh The force of infection from infected mosquito to susceptible human.
This is defined as
(# of bites per human by mosquitoes per day)
× (prob. a human is bitten by an infectious mosquito)
× (prob. transmission occurs | a human was bitten by an infected mosquito)
= (σv
Nv
Nh
)( Iv
Nv
)(βhv) =
σvβhvIv
Nh
. (Time−1)
λv The force of infection from infected mosquito to susceptible human.
This is defined as
(# of bites on a human per mosquito per day)
× (prob. a mosquito bites an infected human)
× (prob. transmission occurs | the mosquito bit an infected person)
= (σv)(
Ih+Irh
Nh
)(βvh) =
σvβvh(Ih+Irh )
Nh
. (Time−1)
Table 2: Description of parameters within the Zika model. Dimensions are provided in parentheses on
the right most side of the table.
2.2 Basic reproductive number
We define the basic reproductive number, R0, as the expected number of secondary infec-
tions by a single infectious individual over the duration of the infectious period within a fully
susceptible population [25]. As there is more than one class of infectives involved, we utilize
the next generation method to derive an explicit formula for R0, defined mathematically
by the spectral radius of the next generation matrix [11]. We follow the process in [39] and
define x = [Eh, Irh , Ih, Ev, Iv, Sh, Rh, Sv]
T ; thus reordering the presentation of populations
from the original system to ensure our calculations possess the correct biological representa-
tion. Let Fi(x) be the rate of appearance of new infections in compartment i. We indicate
the rate of transfer of individuals out of compartment i as V −i (x) and the rate of transfer
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of individuals into compartment i by all other means as V +i (x). Thus, our system can be
expressed in a condensed version as x˙i = Fi(x)− Vi(x) where Vi(x) = V −i (x)−V +i (x) for
i = 1, ..., 8.
Next, we compute F = [∂Fi∂xj (x0)] and V = [
∂Vi
∂xj
(x0)] for the exposed and infected
compartments, namely for 1 ≤ i, j ≤ 5, where x0 = [0, 0, 0, 0, 0,H0 , 0,Kv ] is the disease
free equilibrium state with H0 and Kv being the initial population sizes of humans and
mosquitoes respectively, and obtain the following 5× 5 matrices:
F =


0 0 0 0 βhvσv
0 0 0 0 0
0 0 0 0 0
0 βvhσvKv
H0
βvhσvKv
H0
0 0
0 0 0 0 0


V =


νh 0 0 0 0
−νhψ γh 0 0 0
−νh(1− ψ) 0 γh 0 0
0 0 0 µv + νv 0
0 0 0 −νv µv


Hence, we calculate the Reproductive Number as:
R0 := ρ(FV
−1) =
σv
√
Kvβhvβvhνv√
H0γhµv(µv + νv)
=
√
RhvRvh
where ρ(A) represents the spectral radius of the matrix A, and we have defined the quan-
tities Rhv =
(
νv
µv+νv
)(
σv
µv
)
βhv and Rvh =
(
Kv
H0
)(
σv
γh
)
βvh.
Here, Rhv is the expected number of secondary infections in a fully susceptible human
population resulting from one newly introduced infected mosquito. It is composed of the
product of three terms. The first term, νvµv+νv , represents the probability that an exposed
mosquito will survive the extrinsic incubation period. The second term, σvµv , is the number of
human bites an infectious mosquito would make if humans were freely available. The third
term, βhv, is the probability of transmission occurrence given that a human is bitten by an
infected mosquito. The number of secondary infections in a fully susceptible population
of mosquitos resulting from one newly introduced infected human is represented by Rvh.
This value is also formed by the product of three terms. The first, KvH0 , is the vector to host
ratio. The σvγh term is the maximum number of bites an infectious human will experience
before recovery without impediment to mosquito bites. Finally, given that a susceptible
mosquito bites an infectious human, βvh is the probability of transmission from human to
mosquito. The type reproductive number, or expected number of secondary human cases
resulting from one newly infectious human, is R0
T := (R0)
2 [25].
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3 Incidence Rates and Parameter Estimation
Although the traditional approach when modeling disease dynamics is to assume the total
population within a country is susceptible, we deviate from this convention. Specifically, we
assume the susceptible population depends on the biology and binomics of the Aedes species
as well as the country’s geography and uniquely calculate the at-risk population (described
in the following section). We then use the at-risk population as the size of the initial
susceptible population within simulations. While the deterministic model (1) captures the
dynamics of the epidemic fairly well, we follow the opinion of the authors in [13], namely
that more attention should be paid to how uncertainty in parameter estimates might affect
model predictions. Thus, in Section 3.2, we focus on incorporating and quantifying the
uncertainty of the disease process and the parameter values by means of embedding the
deterministic model into a stochastic process.
3.1 Calculated At-Risk Population
The data utilized herein was reported by the Pan American Health Organization (PAHO)
[30], and is given by the number of cases, both confirmed and suspected, of Zika per week
at the country level for Colombia, El Salvador and Suriname. Simulations performed by
using the entire country population as the number of initially susceptible humans mischar-
acterized the disease dynamics, leading to overestimates in the final size of an epidemic,
see Appendix (Figure 12). Since dengue and Zika occur in the same areas, share a common
vector and have similar asymptomatic rates, we calculate the at-risk population size per
country for a Zika outbreak based on historical data for dengue from 1995 to 2015 within
Colombia, El Salvador, and Suriname [31]. The year of highest incidence for dengue pro-
vides an approximation for the number of susceptible individuals in a fully na¨ıve at-risk
population, which coincides with the dynamics of a newly emerging pathogen, such as
Zika, that would spread rapidly in a completely susceptible population. The World Health
Organization (WHO) released a report on dengue [43], stating “...available results suggest
that the actual number of cases of dengue may range from 3 to 27 times the reported
[dengue] number.” Hence, we use a scalar multiple of the reported number of dengue cases
during the highest incidence rate year to obtain a reasonable at-risk population count for
the number of initial susceptible individuals with regards to a Zika epidemic. Within each
of the three countries, the at-risk population value is strictly less than the total country
population.
Table 3 indicates the year with the highest incidence rate and the reported number
of cases for that year in each country of interest. See the Appendix (Figure 13) for all
historical data on dengue incidence rates for Colombia, El Salvador and Suriname.
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Table 4: Computed At-Risk Population and Other Initial Conditions
Country Original Initial Conditions Shifted Initial Conditions∗ ψ
Dependent variables / Populations
Colombia [432168, 0, 1, 0, 0, 864336, 0, 0] [432163, 1, 0, 1, 4, 864330, 3, 3] 18%
El Salvador [76181, 0, 1, 0, 0, 152362, 0, 0] [75802, 87, 14, 62, 217, 152082, 145, 135] 18%
Suriname [22111, 0, 1, 0, 0, 44222, 0, 0] [22099, 3, 0, 2, 7, 44212, 5, 5] 22%
∗Note: The shifted initial conditions were obtained approximately from Day 38, 118, and 50
of the solution using the original initial conditions for Colombia, El Salvador and Suriname, respectively.
Table 3: Reported dengue values from WHO used to compute the at-risk population
Country Highest Incidence Rate Year Reported Number of Cases
Dependent variables / Populations
Colombia 0.00342 2010 157, 152
El Salvador 0.00875 2014 53, 460
Suriname 0.00580 2005 2, 853
We simulated Model (1) using the ode45 solver in MATLAB with chosen baseline
parameter values (Table 5) while assuming that a single infectious human exists at the
start of the epidemic. The at-risk population size for Colombia is 2.75 times the number of
reported dengue cases from 2010. We estimated the multiplier for the at-risk population
based on the best fit for the currently ongoing epidemic. The at-risk population size for
El Salvador is 1.425 times the number of reported dengue cases from 2014, while the
at-risk population size for Suriname is 7.75 times the number of reported dengue cases
from 2005. The initial size of the susceptible mosquito population is double the number
of the at-risk population per country. When starting our analysis with only one infected
human, the simulated epidemic takes several weeks to ramp up to a detectable (reportable)
level. If we begin simulations on the first day that a case is reported, the simulated
peak occurs after the reported peak. Thus, we use shifted initial conditions (Table 4)
that correspond to the population state sizes obtained approximately on day 38, 118,
and 50 from the original simulation using Model (1) of the epidemics in Colombia, El
Salvador and Suriname, respectively. We then repeat the process of simulating Model (1)
using the shifted initial conditions to obtain solutions for the number of reported cases
whose peak reporting weeks align more closely in time with that of the data. The precise
values of the shifted initial conditions for each country, found in Table 4, are of the form
[Sh, Eh, Irh , Ih, Rh, Sv, Ev , Iv].
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Table 5: Ranges and Chosen Baseline Values for Model Parameters
Parameter Baseline Range Reference
Dependent variables / Populations
1/σv 3.85 2− 5.26 [10, 37, 24]
βhv 0.54 0.1− 0.75 [25, 20, 24]
1/νh 6 3− 12 [3, 16, 15, 20, 22, 40, 44, 24]
1/γh 7 3− 14 [3, 16, 15, 20, 22, 40, 44, 24]
ψ 0.18 0.05− 0.3 [20, 12, 24]
βvh 0.75 0.1− 0.75 [25, 20, 24]
1/νv 10.2 4.5− 17 [20, 41, 1, 2, 24]
1/µv 18 8− 35 [1, 29, 14, 24]
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Figure 2: Solutions of Model (1) are plotted in blue along with the weekly Zika data available from
PAHO shown as green circles. These solutions used the shifted initial conditions (see Table 4) and baseline
parameters (see Table 5). (a) Columbia: cases of Zika were reported first in Colombia on Epidemiological
Week (EW) 32 of 2015. (b) El Salvador: the first Zika cases were reported on EW 38 of 2015. (c) Suriname:
the reporting Zika cases began on EW 37 of 2015.
The number of reported cases from our simulations, using the calculated at-risk pop-
ulation and shifted initial conditions, are compared to the PAHO Zika data in Figure 2.
The solutions, which are similar to the data in peak and general shape, identify reasonable
initial conditions. Although the parameter ranges considered are biologically reasonable, it
is unknown which values within these ranges are the most accurate. To obtain an expected
value for a given parameter and describe the associated uncertainty within this quantity, we
embed the deterministic Model (1) into a stochastic process enabling statistical inference.
This process is described in Section 3.2.
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3.2 An Embedded Stochastic Model
Previous literature has provided biologically relevant parameter ranges (see Table 5) for
the model. However, to obtain insight as to the distribution of these parameters across
their ranges, we embed the deterministic system of ordinary differential equations (1)
within a discrete-time stochastic process to obtain a corresponding stochastic model (2,
3) and perform an analysis in a Bayesian paradigm. This approach adds a probabilistic
component to both the contact/infection process and the disease progression process by
capturing uncertainty at each modeling stage, rather than just within the contact/infection
process [19]. Therefore, embedding deterministic models into stochastic processes serves
to (a) create a stochastic model informed by population-level dynamics which includes
uncertainty in the entire disease process rather than just due to data collection, (b) more
adequately capture uncertainty present in the modeling framework, which is particularly
important in small to medium sized epidemics, and (c) provide a convenient framework for
fast computation of model parameters. The process by which we embed Model (1) into a
stochastic process, [26], is summarized in the following paragraphs.
Previously, we obtained specific rates for the transfer of both humans and mosquitos
between their respective compartments, and these can be used to inform the stochastic
analogues of these parameters. Throughout, we impose that the new model be conservative,
i.e. Sh + Eh + Irh + Ih +Rh = Nh and Sv + Ev + Iv = Nv where Nh and Nv are the total
human and mosquito populations, respectively. The assumption of conservation within
the human population is plausible as the time span of the epidemic is much smaller than
the average lifespan of a human. We hold the mosquito population as constant for the
convenience of calculations and analysis. To approximate a continuous SEIR type model,
we account for all events/transitions that may occur during time interval (i, i + hi] to
be assigned to the related compartment on day i. Thus, the rate of change for a given
population size can be approximated by the difference between the previous and current
time steps. The model now takes the form
Si+hi = Si − E∗i+hi
Ei+hi = Ei + E
∗
i+hi − I∗i+hi
Iri+hi = Iri + ψI
∗
i+hi −RIr∗i+hi
Ii+hi = Ii + (1− ψ)I∗i+hi −RI∗i+hi
Ri+hi = Ri +RIr
∗
i+hi +RI
∗
i+hi
Svi+hi = Svi + dEv
∗
i+hi + dIv
∗
i+hi − Ev∗i+hi
Evi+hi = Evi + Ev
∗
i+hi − Iv∗i+hi − dEv∗i+hi
Ivi+hi = Ivi + Iv
∗
i+hi − dIv∗i+hi .


(2)
We index time by i, and the temporal offset, hi, which may not be constant but is known.
All quantities represent counts and quantities denoted by an asterisk represent transition
counts. In regards to the terms ψI∗i+hi and (1−ψ)I∗i+hi , the parameter ψ may yield values
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which are not integer counts. To be more liberal with the reporting size we calculated
the smallest integer not less than the corresponding value of ψI∗i+hi . To be more con-
servative with under-reporting size we calculated the largest integer not greater than the
corresponding value of (1− ψ)I∗i+hi . When individuals can transition into a compartment
via multiple routes, (e.g., recovered individuals can recover either with or without being
reported as infected, RIr∗i+hi and RI
∗
i+hi
), two letters are used to denote the transition. In
these cases, the first letter denotes to which compartment the individual transitions and
the second denotes the compartment from which the individual transitions. The transi-
tion compartments which represent birth/death counts of the mosquito popultion on day
i + hi are denoted, dEv
∗
i+hi
and dIv∗i+hi . Note that these values are drawn based on the
calculated population sizes at time i + hi. The compartments are labeled as follows: S
- susceptible humans, E - latently infected humans, Ir - infectious reported humans, I -
infectious unreported humans, R - recovered humans, Sv - susceptible mosquitoes, Ev - la-
tently infected mosquitoes, Iv - infectious mosquitoes. Finally, the stochastic components
of the model are given by
E∗i+hi ∼ Bin
(
Si, 1− exp(−λhhi)
)
, I∗i+hi ∼ Bin
(
Ei, 1− exp(−νhhi)
)
RIr∗i+hi ∼ Bin
(
Iri, 1− exp(−γhi)
)
, RI∗i+hi ∼ Bin
(
Ii, 1− exp(−γhi)
)
Ev∗i+hi ∼ Bin
(
Evi, 1− exp(−λvhi)
)
, Iv∗i+hi ∼ Bin
(
Ivi, 1− exp(−νvhi)
)
dEv∗i+hi ∼ Bin
(
Evi+hi , 1− exp(−µhhi)
)
, dIv∗i+hi ∼ Bin
(
Ivi+hi , 1− exp(−µhhi)
)
.


(3)
4 ABC Algorithm and Computation
Previous investigations [12, 25, 20, 41] have established biologically accepted ranges for the
parameters Θ = [σv, βhv, νh, ψ, βvh, νv, µv] used within (1), but the conversion of Model
(1) to Model (2, 3) will incorporate uncertainty into the disease process, and thus the
values of these parameters. The stochastic model (2, 3) also allows for Bayesian inference
on parameter posteriors which have the form
f(Θ|Y ) ∝ f(Y |Θ)π(Θ)
where f(Y |Θ) is the stochastic data model, which for fixed values of Θ can be used to
generate the random epidemic process, and π(Θ) is the prior distribution of the parameters.
Thus, given both the data model and the prior distribution, we are able to calculate the
posterior distribution f(Θ|Y ) up to a proportionality constant. This serves to update the
distribution of the biologically accepted parameter ranges based on the actual epidemic
data which we denote as Y .
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The data model is constructed as a product of binomials with different sample sizes
and probabilities across every time point. Determining a Maximum Likelihood Estimate
(MLE) to provide a point estimate and standard deviation for parameters may provide
estimates outside of the valid biological ranges. In SEIR models, Markov Chain Monte
Carlo (MCMC) methods produce parameter autocorrelations in chains which becomes
problematic for tuning. We can avoid these obstacles by using Approximate Bayesian
Computation (ABC). This method was introduced by [36] to obtain an approximation of
the true posterior distribution, f(Θ|Y ). ABC samples from the posterior by randomly
selecting parameter values from the prior that could adequately generate the data. In
particular, random draws, Θ∗, from the prior distribution produce generated data sets, X,
which are then compared to a given epidemic data set, Y , by means of a chosen distance
metric, ρ(X,Y ). Those values of Θ∗ that generate data sets which fit the given data will
be accepted as valid draws from the posterior distribution, and this implicitly conditions
the posterior on Y . The algorithm of the computation is as follows, where N is the total
number of accepted generated data sets X:
For j ≤ N
1. Draw Θ∗ ∼ Unif(ak, bk), where (ak, bk) is the corresponding parameter range found
in Table 6 for all k = 1, ..., 7.
2. Generate X, time series data of the number of reported infectives, from Model (2, 3)
3. Calculate fitness of data using ρ(X,Y )
4. Set Θ[j] ← Θ∗ if ρ(X,Y ) ≤ ǫ and set j ← j + 1 else return to Step 1.
Table 6: Ranges for Uniform Distributions
Parameter Range
Dependent variables / Populations
1/σv 0.5− 10
βhv 0.01 − 1
1/νh 2− 20
1/γh 7
ψ 0.05 − 0.35
βvh 0.01 − 1
1/νv 4− 20
1/µv 7− 50
Note: We expand the ranges given in Table 5 as these are educated approximations and
there is uncertainty with regards to the true range of most of these parameters.
The metric, ρ(X,Y ), is considered a distance between the generated data set, X, and
the observed data set, Y , typically based on sufficient statistics of the parameter space Θ.
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If ρ(X,Y ) is small enough, i.e., ρ(X,Y ) ≤ ǫ for some fixed small value ǫ > 0, then
f(Θ|ρ(X,Y ) ≤ ǫ) ≈ f(Θ|Y ).
One often uses sufficient statistics in defining ρ(X,Y ). These are statistics for which the
data distribution conditioned on the sufficient statistic is free of Θ (e.g., the sufficient
statistic contains all information about Θ that the full data set contains). By definition,
the full data set is a sufficient statistic for Θ. Since a sufficient statistic of lower dimension
than the full data set cannot be readily computed for our model, we consider a pointwise
envelope metric comparing point by point the L1-norm at every time step. Thus, if every
data point of X and Y is close, then it directly follows that any statistics computed from
X and Y , including sufficient statistics, will also be close. For the ABC method, the exact
posterior distribution of Θ can be found by accepting the simulated data set in which
X = Y . This is computationally infeasible, however, so we instead consider X, such that
Xt
Yt
∈ (ǫ1, ǫ2) for all time steps t with a corresponding peak week and epidemic duration to
Y , as an acceptable epidemic. We call (ǫ1, ǫ2) the envelope of tolerance around the observed
data set, Y , which is a common method for assessing a stochastic SEIR model fit [21, 34, 35].
In Figure 3, the observed data set is compared to randomly generated data sets without
calculating a metric for validation of the drawn parameter values. Figure 3 shows that many
randomly drawn and biologically accepted values of Θ generate epidemic outcomes which
have distinctly different characteristics than the observed epidemic. Conversely, Figure 4
demonstrates that epidemic outcomes of the accepted Θ∗ values generate epidemics with
similar characteristics to that of the observed epidemic in regards to the total number of
new infections each day, peak week occurrence, and peak value. Figure 4(b) and 4(c) show
generated epidemics similar to the data in both peak and duration. Note that this does not
occur in Figure 4(a). The accepted parameter values obtained using the ABC method yield
outbreaks which vary greatly in peak occurrence, leading us to conclude that the dynamics
of the country-level data are different than those in the deterministic model. Therefore
the ABC method does not generate infectious curves similar to the Colombia data. Figure
4(a) was generated from acceptances using an envelope of (1/20, 20). A tighter envelope
of (1/10, 10) was computed; however, the method ran for approximately 35 days to obtain
the same number of acceptances as the (1/20, 20) envelope with no visible changes in the
same plot as Figure 4(a). Because acceptances for tighter envelopes are not possible, we
can conclude the model is improperly specified to capture the dynamics of Colombia at the
country level. Reasons for this outcome are discussed in Section 6.
15
05000
10000
15000
20000
25000
0 10 20 30 40
Time in weeks
R
ep
or
te
d 
Ca
se
s 
of
 Z
ika
(a) Colombia
0
2000
4000
0 10 20 30 40
Time in weeks
R
ep
or
te
d 
Ca
se
s 
of
 Z
ika
(b) El Salvador
0
500
1000
1500
0 10 20 30 40
Time in weeks
R
ep
or
te
d 
Ca
se
s 
of
 Z
ika
(c) Suriname
Figure 3: Each subfigure contains the results of using randomly drawn parameter vectors in Model (2, 3)
to generate outcomes of the epidemic in which a metric is not applied. For all three countries the biologically
accepted parameter values generate epidemics that vary greatly from the characteristics of the observed
epidemics, particularly in the peak and duration.
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Figure 4: Each subfigure compares the stochastic model epidemic outcomes from 500 of the 10,000
accepted randomly generated parameter vector draws (gray) and the observed epidemic in each country
(black). The envelope size is (1/20, 20) for Colombia (a) with the occurrence of peak week within ±4 weeks
of the known peak week and the peak number of new infections less than or equal to a 20% deviation from
the true value. The envelope size for El Salvador (b) is (2/3, 2) with the occurrence of peak week within ±2
weeks of the known peak week and the peak number of new infections less than or equal to a 5% deviation
from the true value. The data from Suriname (c) was compared to generated data with an envelope size of
(1/4, 4) and the occurrence of peak week within ±2 weeks of the known peak week and the peak number
of new infections less than equal to a 5% deviation from the true value.
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Figure 5: Subfigures (a) and (c) display the kernel density plots of the proportion of reported infectious,
ψ, with various envelope sizes for El Salvador and Suriname, respectively, while subfigures (b) and (d)
show the kernel density plots of the reproductive number, R0 for El Salvador and Suriname, respectively.
As the legends indicate, an envelope size of (2/3, 2) is displayed by the black curve, an envelope size of
(1/4, 4) is displayed in blue, the red curve represents an envelope size of (1/10, 10), and similarly the green
curves indicate an envelope size of (1/20, 20) using green. Note that envelopes of all four sizes were able to
generate acceptances from the El Salvador data while the data from Suriname only allowed for acceptance
to be generated from envelope sizes of (1/4, 4), (1/10, 10), and (1/20, 20).
Figure 5 depicts the effect of generating accepted epidemics with smaller and smaller
envelopes of tolerance on the posterior distributions. We plot the kernel densities of both
the reporting rate, ψ, and reproductive number, R0, distributions for El Salvador and
Suriname. While only two parameters are shown here, the same observations are found
in the kernel density plots of the other parameters of interest. We see in Figure 5 that
envelopes of various size produce similar but different kernel densities, with the tighter
envelopes producing a more peaked density distribution. A slight shift in the peak of the
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kernel densities is observed in Figures 5(a) and 5(d). This would indicate the need to
shrink the envelope further to obtain an estimation that is closer to the true posterior
distribution. However, attempts to generate data sets satisfying tighter envelopes could
not produce acceptances, indicating that these envelope sizes are the best possible fits of
the stochastic SEIrIRSvEvIv model to the observed country-level data. Further analysis
would require refining the dynamics of Model (1) and Model (2,3) or using data at a more
refined spatial scale.
5 Results
We assigned uniform distributions to the accepted biological ranges found in Table 6.
After 10,000 acceptances from the ABC algorithm, the histograms and kernel densities for
selected parameters from El Salvador are given in Figures 6 and 8. Selected parameters
from Suriname are given in Figures 7 and 8. Figure 9 displays the number of reported
cases from the generated epidemics based on 10,000 accepted parameter values. The time
series of the number of total cases during the generated epidemics of both reported and
unreported infectives is found in Figure 10. The histogram and kernel density plots of the
total number of Zika virus cases, reported and unreported are shown in Figure 11.
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Figure 6: ABC generated histograms and kernel density plots for the reporting rate, ψ,
transmission rate for the human population, σvβhv, and mosquito population, σvβvh in El
Salvador.
Table 7: Selected Parameter Statistics for El Salvador
ψ σvβhv σvβvh
Dependent variables / Populations
mean 0.1654 0.2808 0.3053
median 0.1593 0.2124 0.2130
mode 0.1501 0.1372 0.1091
95% C.I. [0.1248, 0.2205] [0.0191, 0.7782] [0.0119, 0.9244]
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Figure 7: ABC generated histograms and kernel density plots for the reporting rate, ψ,
the force of infection for the human population, σvβhv, and mosquito population, σvβvh in
Suriname.
Table 8: Selected Parameter Statistics for Suriname
ψ σvβhv σvβvh
Dependent variables / Populations
mean 0.1877 0.1705 0.4352
median 0.1777 0.1429 0.3365
mode 0.1693 0.0998 0.2069
95% C.I. [0.1304, 0.2717] [0.0165, 0.4054] [0.04287, 1.1241]
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Figure 8: ABC generated histograms and kernel density plots of the Reproductive Number
for El Salvador (a) and Suriname (b).
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Table 9: Reproductive Number Statistics per Country
R0 El Salvador Suriname
Dependent variables / Populations
mean 2.2055 2.4225
median 2.0854 2.3062
median2 4.3487 5.3186
mode 1.9174 2.0901
95% C.I. [1.4664, 3.1658] [1.6526, 3.4704]
Note: The median2 is an approximation of the type of reproduction number (i.e. human-to-human)
as opposed to R0, which is the single generation reproduction number.
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Figure 9: Histogram with kernel density plot of the total number of reported Zika virus
cases generated from the ABC accepted parameter values for El Salvador (a) and Suriname
(b).
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Figure 10: Generated time series data (grey) for the total number of Zika cases (reported
+ unreported) from the ABC-accepted parameter values as compared to the observed data
(black) reported by PAHO for El Salvador (a) and Suriname (b).
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Figure 11: Histogram and kernel density plot of generated total number of Zika virus cases,
both reported and unreported, from the ABC accepted parameter values for El Salvador
(a) and Suriname (b).
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Table 10: Statistics for the Generated Total Cases (Reported and Unreported) per Country
El Salvador Reported Cases Total Cases
Dependent variables / Populations
mean 12107 72721
median 11810 73395
mode 11158 75457
95% C.I. [9606,15321] [67317, 75889]
PAHO data 11825
Suriname Reported Cases Total Cases
Dependent variables / Populations
mean 4132 21390
median 3975 21647.5
mode 3758 22018
95% C.I. [3013, 5697] [19853,221027]
PAHO data 3042
6 Conclusions and Discussion
Within the present study, a new stochastic model was formulated to describe the spread
of the Zika virus within Colombia, Suriname, and El Salvador. The variability in per
capita susceptibility within each country was introduced by uniquely calculating the at-
risk population based on historical data for dengue virus, whose epidemic characteristics
are similar to that of Zika. The initial population state sizes were fit to this data in order
to create similar values of weekly reported cases of Zika, both suspected and confirmed,
to those reported by the PAHO using baseline values of parameters to evaluate Model
(1). Once the at-risk population was estimated, the initial population state sizes for these
nations were fixed in order to estimate parameter values and obtain more informative
distributions than the accepted biological parameter ranges. The deterministic system (1)
was then embedded into a stochastic process to obtain a more general stochastic model
(2, 3). For each of the three nations, an ABC algorithm was implemented using (2, 3) to
compute approximate posterior distributions of the parameters conditioned on the data.
By obtaining these posterior distributions, the uncertainty in parameter values for each
country can be quantified by way of informative statistics, such as the mean, mode, median
and variance, to more accurately describe rates within the system.
Properties of the disease within El Salavador and Suriname were accurately described
by the model. El Salvador is estimated to have a mean reporting rate of 16.5% which is near
the upper bound of the previous estimate of [20] with a credible interval of [12.5%, 22%].
The mean values of the forcing terms, λh and λv, are approximately 0.28 and 0.31 with
credible intervals of [0.0191, 0.7782] and [0.0119, 0.9244], respectively. Suriname has a mean
reporting rate greater than the predicted interval of [20] at 18.8% with a credible interval
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of [13%, 27%]. The forcing terms of Suriname, λh and λv, had mean values of 0.17 and
0.43 with credible intervals of [0.0165, 0.4054] and [0.0429, 1.1241], respectively. The basic
reproductive number, R0, was defined such that R0
2 yields the number of secondary human
infections within a fully susceptible population arising from a single new human infection.
In Suriname, the mean value of R0
2 was 5.31, while the mean reproductive number was
4.35 in El Salvador. These quantities are similar to other predictions for the mean of R0
2
found in [28, 38].
Though this analysis has provided additional insight into the spread of the disease, our
methods were unable to accurately estimate the aforementioned statistics for Colombia
(see Section 4) as the ABC method revealed a poor fit for the data obtained from this
nation. One possible reason for this poor fit could be the appearance of a second peak in
the epidemic, see Figure 2(a). While there is a distinct and large peak during EW 26, a
smaller second peak occurs during EW 34. This second peak may result from reporting
error as this data was in no way cleaned once obtained from the PAHO website. Another
possible explanation is a second outbreak in a disjoint location from the first outbreak. In
particular, the extreme topographical variations within Colombia could lead to a delay in
the spread of the disease across the entire country. Thus, we conclude that the epidemio-
logical characteristics of Zika in Colombia must be studied at a more granular spatial level,
differentiating amongst regions or even counties and cities.
We also estimated the total number of infected people in El Salvador to be 72,721 (with
an estimated 12,107 reported cases) and the total number of people infected in Suriname to
be 21,390 (with an estimated 4,132 reported cases). So, about 95% of the at-risk (high-risk)
populations were infected by the end of the outbreak. The predicted reported country-level
incidence for El Salvador is 0.0019 and for Suriname is 0.0073. However, the true country-
level incidence for El Salvador is predicted to be 0.0119 while for Suriname it is 0.0396
assuming total populations of 6,117,145 and 540,612, respectively. From a public health
perspective, our model indicates that about 6 times as many people were infected than were
reported in El Salvador and 5 times as many were infected than were reported in Suriname.
Depending on the percent of the at-risk population that was pregnant during the outbreak,
our model suggests that a larger number of birth defects than indicated by the reported
number of cases could be expected in these countries. Interestingly, although the values for
the mosquito extrinsic incubation period and mosquito lifespan had relatively wide ranges
even among mean, median, and mode values, the probability of a mosquito surviving the
incubation period (Tables 12 and 13) was quite similar across statistics and countries at
about 60%. This corresponds to the extrinsic incubation period lasting around 2/3 of the
average mosquito lifespan. A major difference between predicted parameter values for El
Salvador and Suriname occurs in the transmission probabilities. While the values for βhv
and βvh for El Salvador were similar (both estimated to be about 0.42), in Suriname, the
mosquito-to-human probability of transmission, βhv was consistently less than half that of
the human-to-mosquito transmission, βvh, with a median of 0.21 and 0.56, respectively.
Since these terms capture many intrinsic uncertainties in the transmission process, it is
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hard to interpret the meaning of this difference. It could be an artifact of the model or
could indicate a reduced efficiency of the mosquitoes in Suriname in passing on the virus.
In conclusion, our research provides important parameter estimates for the spread of
Zika in El Salvador and Suriname, along with uncertainty quantification and credible inter-
vals for those parameters. We estimated the basic and type reproduction numbers and the
total number of people infected - quantities needed to inform assessments of economic cost
and risk, among other factors. We found that the type reproduction number is higher in
Suriname than in El Salvador, indicating a higher risk in Suriname. This could be explained
by differences in climate between the two countries or in other socio-economic or geographic
factors affecting mosquito-borne disease transmission. Additionally, our methods could be
applied to other countries or regions experiencing outbreaks to estimate region-specific pa-
rameters and provide decision makers with important information about surveillance and
control both at present and in the future. Another advantage of this method is that it
can indicate what scale is appropriate for these calculations. For example, we found that
a country-level analysis of the Colombia data was not appropriate. In the future, it would
be interesting to apply the model to a regional Colombia data set.
In future studies, the initial population state sizes obtained in the calculations of the
respective at-risk populations could be considered parameters themselves. Hence, one
could perform a statistical analysis on acceptable ranges for such initial values to quantify
the uncertainty of these populations. For instance, this could be done by generating a
posterior distribution for the initial susceptible population for each country, as well as the
parameters in the system. Additionally, the mosquito population for each country was
assumed to be constant for convenience. However, utilizing a more realistic model of the
total mosquito population which changes in time (similar to the methods in [25]) may yield
different results, and this would also be a suitable direction for future research. Finally, the
recovery period, 1/γh, was held constant in the current study due to the assumption that its
mean value had been medically established. Still, another investigation using the methods
developed herein, but considering a uniformly-distributed prior for the recovery period, may
provide better insight into the distribution and expected value of this period. We conclude
that additional studies are needed to fully understand Zika virus transmission dynamics.
However, our research suggests that the reporting rates in El Salvador and Suriname are
quite low and thus, additional surveillance systems may be needed to measure the true
burden of Zika in these countries.
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8 Appendix
8.1 Results of Model 1 using total country populations as the initial size
susceptible populations
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Figure 12: The time series for the number of reported infectives as calculated using Model
(1) with the initial number of susceptible people equal to the total population (solid blue
line) as compared to the PAHO data (dotted green) as reported 06.22.2016 per country. The
total populations as reported for 2015 are 48,010,049 (Colombia), 6,117,145 (El Salvador),
540,612 (Suriname) accessed 6.22.16 at http://countrymeters.info/.
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Figure 13: Reported rates of incidence are calculated based on the number of reported
cases documented [31] divided by the reported country population in the corresponding
year [8].
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8.2 Other parameter distributions
Biting Rate
D
en
si
ty
2 4 6 8
0.
0
0.
2
0.
4
0.
6
(a) El Salvador - 1/σv
Probability of transmission from mosquito to human
D
en
si
ty
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
5
1.
0
1.
5
(b) El Salvador - βhv
Duration of human intrinsic incubation period
D
en
si
ty
5 10 15 20
0.
00
0.
10
0.
20
0.
30
(c) El Salvador - 1/νh
Probability of transmission from human to mosquito
D
en
si
ty
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
5
1.
0
1.
5
(d) El Salvador - βvh
Duration of mosquito extrinsic incubation period
D
en
si
ty
5 10 15 20
0.
00
0.
10
0.
20
(e) El Salvador - 1/νv
Lifespan of a mosquito
D
en
si
ty
10 20 30 40 50
0.
00
0.
04
0.
08
0.
12
(f) El Salvador - 1/µv
Probability exposed mosquito survivial
D
en
si
ty
0.3 0.4 0.5 0.6 0.7 0.8 0.9
0.
0
1.
0
2.
0
3.
0
(g) El Salvador - νv
µv+νv
Figure 14: Distributions for the various parameters used for modeling Zika dynamics in El
Salvador
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Figure 15: Distributions for the various parameters used for modeling Zika dynamics in
Suriname
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Table 11: Statistics for the Other Parameter Values for El Salvador
1/σv βhv 1/νh βvh 1/νv 1/µv
νv
µv+νv
Dependent variables / Populations
mean 1.6894 0.4201 5.5626 0.4260 8.4171 14.9655 0.6206
median 1.3874 0.3817 3.8095 0.3882 7.0799 11.4532 0.6315
mode 0.7397 0.0851 2.5506 0.0760 4.8253 8.4276 0.6451
95% C.I. [0.5004, 3.8294] [0.01274, 0.9302] [2.0001, 15.5402] [0.0104, 0.9289] [4.0001, 17.0355] [7.1432, 35.9220] [0.3475, 0.8832]
Table 12: Statistics for the Other Parameter Values for Suriname
1/σv βhv 1/νh βvh 1/νv 1/µv
νv
µv+νv
Dependent variables / Populations
mean 1.6819 0.3004 6.6144 0.5602 8.3111 16.1174 0.6369
median 1.3684 0.2141 4.8592 0.5657 6.9234 12.4293 0.6453
mode 0.7375 0.0702 2.7695 0.8657 4.8375 8.7023 0.6521
95% C.I. [0.5002, 3.8328] [0.0101, 0.8456] [2.0001, 16.8145] [0.1358, 0.9985] [4.0000, 16.9617] [7.1467, 38.2319] [0.3699, 0.8961]
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8.3 Other Reproductive Number distributions
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Figure 16: Displayed are the individual to individual reproductive ratios. For El Salvador
the mosquito to human ratio histogram and kernel density is (a) while the human to
mosquito ratio histogram and kernel density is (b). (c) and (d) show the histogram and
kernel density plots of the mosquito to human and human to mosquito ratios for Suriname,
respectively.
Table 13: Statistics for the Individual to Individual Reproductive Numbers
El Salvador - Rhv El Salvador - Rvh Suriname - Rhv Suriname - Rvh
Dependent variables / Populations
mean 2.4588 4.2743 1.6667 6.0925
median 1.5509 2.9813 1.1414 4.7115
mode 0.9238 1.5273 0.6250 2.8961
95% C.I. [0.1519, 7.4016] [0.1663, 12.9415] [0.1473, 4.8498] [0.6002, 15.7379]
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